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Abstract
Introduction: Depression in older adults has become a major problem for public health. A high percentage of this
population is under-diagnosed in primary care.
The objectives of this work were firstly, to investigate the causes, risk factors, cognitive profile, functional status
and quality of life of patients with geriatric depression, and secondly, to make a follow up of these patients.
Materials and methods: Patients who consulted for memory problems associated with depression were
recruited during the years 2005-2007. A semi-structured neuropsychiatric interview, an extensive neuropsychological
battery, and complementary studies were performed.
Results: One hundred and one depressive patients and 25 normal controls were evaluated. There was a
significant prevalence and incidence of depression in the geriatric population. Significant differences (p<0.05) were
found between depressive patients and controls in dyslipidemia, heart disease, cerebrovascular disease, inadequate
family support, family history of depression and inactivity (OR 6.5). A global cognitive impairment was frequently
associated with depression. Depression caused an alteration in functional status. Follow up results: From the 101
patients evaluated only 61 attended to the follow up visit (61.4%). All patients were indicated antidepressant
treatment. Of these, only 36 patients continue with the treatment indicated in the baseline visit. Of the patients who
were in antidepressant treatment (n=36) 46.6% had an excellent to good response, and 13.3% had a response from
fair to poor. The main causes of poor response were adverse effects, low-dose and treatment neglect. Of the
reevaluated patients, 56.6% improved in cognition or mood. The greatest improvement was observed in depression
and anxiety affective symptoms. Within the cognitive profile, memory and attention trend to improve with medical
treatment.
Conclusion: Depression is a prevalent disease in the elderly population. It is important to implement health
policies to inform the community, prevent associated risk factors, and promote appropriate treatments and
rehabilitation. This condition not only affects the patient but also their environment.
Keywords: Depression; Geriatrics; Risk factors; Cognitive
impairment-treatment; Follow up
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Introduction
More than 350 million people are affected by depression making it
one of the most common disorders in the world. It is the biggest cause
of disability, and as many as two-thirds of those who commit suicide
have the condition. But although depression is common, it is often
ignored [1].
Depression in older adults is a very common condition that creates
a major problem for public health [2]. A high percentage of this
population is under-diagnosed in primary care [3].
It has been demonstrated that depression is associated with
cognitive impairment due to vascular factors [4], degenerative process
[5], or emotional compromise. Moreover, it could be also related with
social and psychological distress situations [6,7], or co-morbid clinical
diseases (chronic diseases, cancer, neurological diseases, etc.) [8,9].
It is frequently under-diagnosed in clinical practice, mostly in those
patients with late onset geriatric depression that develop subsyndromal
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depressive symptoms where memory and other cognitive functions are
mildly impaired [10,11]. These patients minimize their symptoms
thinking that it is normal to have them due to their social problems or
their co-morbid diseases. These factors attempt against an effective
treatment for depressive syndromes and probably these symptoms will
last for months or even years without a proper treatment.
The objectives of this work were firstly, to investigate the causes, risk
factors, cognitive profile, functional status and quality of life of patients
with geriatric depression, and secondly, to make a follow up of these
patients.
Materials and Methods
Patients who consulted for memory problems associated with
depression to a memory clinic from a public (Memory Research
Center, Zubizarreta Hospital) and a private Hospital (SIREN-CEMIC
University Hospital) were recruited during the years 2005-2007. A
semi-structured neuropsychiatric interview and an extensive
neuropsychological battery with complementary studies were
performed.
Inclusion criteria
Patients who present depressive symptoms due to psychiatric causes
or are related to dementia (clinical dementia rating scale 1-CDR).
Patients more than 55 years and less than 80 years old. Patients with
Hamilton depression scale more than 9 points and Beck depression
inventory more than 9 points.
Exclusion criteria
Patients with schizophrenia or schizoaffective disorder. Patients
with Hamilton depression scale less than 10 points and Beck
depression inventory less than 10 points. Patients less than 55 years
old. History of drug or alcohol abuse. Moderate or severe dementia
(CDR 2, or CDR 3).
All patients were assessed using a semi-structured neuropsychiatric
interview (administered by specialized psychiatrists and neurologists).
Depressive syndromes were categorized into different diagnoses
according to the diagnostic and statistical manual of mental disorders
(DSM IV) and international codification of diseases (ICD 10) criteria,
using schedules for clinical assessment in neuropsychiatry (SCAN 2.1)
[12,13].
Other psychiatric scales were performed including Hamilton
depression scale and Beck depression inventory to evaluate level of
depression, and Hamilton anxiety scale to determine level of anxiety
[14-16]. Also, neuropsychiatric inventory (NPI) was administered to
the patient’s caregivers in order to collect more data from the patients´
behavior [17].
Patients and normal controls were matched by age, education and
overall cognitive status using the mini-mental state examination
(MMSE) and the clinical dementia rating (CDR) instrument. CDR was
administered as a severity rating scale [18,19].
We assessed vascular risk factors and co-morbidities such as high
blood pressure (HBP), high cholesterol level (HCL), heavy smoking,
cerebrovascular disease (CVD), and heart diseases. Additionally, we
evaluated sociological risk factors of depression, such as marital status
(couple or single, single patients being those who live alone or have no
emotional support), and level of activity (active: currently working or
else engaged in physical, cognitive, social or recreational activities, or
passive: not working and without activities). In order to investigate the
different cognitive profiles, each patient underwent an extensive
neuropsychological battery to evaluate the following areas of cognitive
ability:
• Orientation: MMSE
• Attention: Digit span (forward and backward); Trail making test
“A” [20,21].
• Language: Boston naming test (BNT) [22]; vocabulary; semantic
fluency (SF) [23]; verbal intellectual quotient (IQ) [24]; verbal
fluency (VF) [23].
• Memory: Signoret memory battery; episodic memory: immediate
logic memory (ILM), delayed logic memory (DLM); verbal serial
learning (VSL), delayed serial memory (DSM), cued recall (CR),
recognition (Recog) [25]. Buschke selective reminding test, free
recall (BSRT fr); Buschke selective reminding test, cued recall
(BSRT cr) [26].
• Abstraction and reasoning: Similarities and matrix reasoning [24].
• Visuospatial abilities: Block design; clock-drawing test [24,27].
• Executive functions: Trail making test “B”; VF [21,23]
• IQ: Wechsler abbreviated scale of intelligence (Weschler) [24]
• Lawton and Brody activities of daily living scale [28].
Laboratory Analysis Were Done
Neuroimaging
Computed tomography scan (CT) or magnetic resonance imaging
(MRI) were done in patients with neurological symptoms.
Written informed consent was obtained from each subject after they
had been given a full explanation of the study. The research was
performed in accordance with the International Conference of
Harmonization Good Clinical Practice guidelines, the latest revision of
the 1964 Helsinki Declaration, and the Buenos Aires Government
Health Authorities regulations [29].
Follow up
After recruiting and evaluating the depressive patients and normal
controls at baseline, we indicated antidepressant treatment (SSRI´s
type: sertraline 25-50 mg per day or escitalopram 10 mg per day).
Follow-up visits were performed after at least 6 months of treatment.
Data analysis
Statistical Package SSPS 15.1 was used to analyze data.
Demographic variables for both populations (patients and controls) as
well as the results of neuropsychiatric and neuropsychological general
global tests were expressed as means, standard deviation and medians.
Quantitative variables were compared using Student T test for
different groups (independent samples) and Student T test (related
samples) for the comparison of the follow up of a group. The
relationship between qualitative variables was compared by the chi-
squared test. Predictive factors for depression were analyzed using the
odds ratio (OR) with 95% confidence intervals (95% CI).
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Results
Demographic data
A hundred and one depressive patients and 25 normal controls were
evaluated. There was a significant prevalence and incidence of






Age 66.7 (8.9) 64.4 (6.8)
Educational level 8.73 (4.4) 11.7 (4.1)
Gender (male/female) 22/79 10/15
Activity level (active/passive) 39/62 20/5
Marital status (couple/single) 58/43 21/4
Table 1: Demographic data.
Diagnosis of Depression Mood Disorder
In the study population, 36 patients with mayor depression and 34
patients with dysthymia were diagnosed. From the patients with Major
Depressive Disorder, 7 had bipolar disorder. Of the patients with
Depression due to Medical Conditions: 10 had Vascular Dementia, 10
Alzheimer’s type Dementia and 6 Frontotemporal type Dementia; all of
them were CDR 1 (mild dementia) (Table 2).
Diagnosis Number of Patients
Major depressive Disorder 36
Dysthymia Disorder 34
Depression due to Medical Condition 26
Unspecified Mood Disorder 5
Table 2: Depression mood disorder. Diagnosis according to DSM IV
criteria.
Neurological examination






Abnormal neurological examination 45
Table 3: Clinical findings in neurological examination.
Laboratory
Media and standard deviation of the following tests were evaluated:
Hematocrit, eritrosedimentation, glycemia, cholesterol, THS, B12
vitamin, folic acid. Findings showed in Table 4.
Mean (S.D.) Range
Hematocrit 39.5 (+/- 3.6) 29-51
Erythrocyte sedimentation rate 18.0 (+/-13.1) Feb-63
Glycemia 98.20 (+/-28.5) 73-244
Cholesterol 219 (+/-40.6) 150-327
TSH 2.30(+/-1.99) 11.2-0.4
B12 vitamin 512.8 (+/-422) 106-2000
Folic acid 10.3 (+/- 4.35) 3.5-24
Table 4: Laboratory tests.
Neuroimaging results are resumed in Table 5.
Normal Vascular
disease
Atrophy Atrophy + vascular
disease
19 patients 15 patients 25 patients 19 patients
Table 5: Brain neuroimaging.
Risk Factors
Significant differences (p<0.05) in dyslipidemia, heart disease,
cerebrovascular disease, inadequate family support, family history of
depression and passive patients were found compared to normal
controls. It was demonstrated that inactivity produces a relative risk of
6.5 of developing depression (Tables 6 and 7).
Hypertension
We observed that 48 patients (47.5% of the study population) have
diagnosed and treated hypertension. It was also noted that 13 patients
had systolic blood pressure greater than 140 and diastolic blood
pressure greater than 95; 5 of these patients were not diagnosed as
hypertensive (12.8% of the study population).
Diabetes
It was found that 11.1% of patients had DBT type 2. Of these, 5.5%
had glycemic control beyond the upper normal limit (greater than 110
mg/dl).
Dyslipidemia
45.5% of patients had high cholesterol levels, from them 46.6% had
values more than 200 mg/dl. The average cholesterol level for all
patients was higher than accepted normal values (230 mg/dl).
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Psychiatric history
53 patients had a depressive episode before 60 years old and 48
patients had depressive episodes after that age. Total population was
divided in two groups: late onset depression and early onset
depression. The late onset depression patients were defined as those
who had a depressive episode after they were 60 years old [30].
Antidepressant treatment: 43 patients had never taken
antidepressant until baseline visit
Psychiatric hospitalisations: 4 patients
Suicide attempt: 5 patients
Electroconvulsive therapy: 1 patient




Hypertension 46 7 NS
Diabetes 46 7 NS
Dyslipidemia 5 0.02 3.3(1.16-9.6)
Cardiac disease 29 2 0.033 4.5 (1.01-20.6)
Thyroid disease 21 2 NS
Stroke 13 1 NS
Cerebrovascular disease 25 1 0.016 8.5(1.1-66.7)
Cigarette smoking 29 8 NS
Other illness 65 15 NS
Table 6: Medical risk factors.
Family history
In the depressive group there were 52 patients with family
psychiatric history, being the most frequent conditions depression and
dementia. On the other hand, there were 11 individuals in the control
group with family psychiatric history. When we evaluated the
Depressive group there were 33 relatives with depression history and
only 3 in the control group.
Variables Depressive group (N=101) Control group (N=25) P Estimated risk (CI)
Currently working 62 5 <0.001 6.5 (2.26-18.8)
Family support 35 4 0.035 3.2 (1.04-10.35)
Family depression history 33 3 0.038 3.6 (1.01-12.9)
Civil status 58 21 NS 0
Table 7: Psychiatric and Sociologic risk factors in 101 patients and 25 normal individuals.
Medications
Only four controls (16%) take three drugs within which there are
preventive medications such as aspirine. Ten controls take between 1-2








One (1) 4 9
Two (2) 11 7
Thee (3) 20 3
Four (4) 25 4
Five (5) 13 0
Six (6) 9 0
Seven (7) 13 0
Eight (8) 4 0
Table 8: Daily medication, comparison of depressed patients (N: 100)
with normal controls (n=23).
Neuropsychological variables
Cognitive profile. A global cognitive impairment (the majority
having subcortical profile) was associated with depression (Table 9).
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Activities of daily living
We used an activity of daily living scale (ADL). It was filled by the
patient and a relative. The objective was to compare the information
provided by both of them. Each item was value in three ways: 0:
independent; 1: partial dependence; 2: total dependence. The ADL
total mean informed by patients was 1.36 (S.D. 2.4) rank between 0-14;







Paragraph recall 4.66 ± 2.43 7.91 ± 1.8 0.0001**
Paragraph delay
recall,
4.27 ± 2.5 7.56 ± 2.0 0.0001**
List of words 7 ± 2.44 9.76 ± 1.6 0.0001**
Retention 4.9 ± 3.1 8.41 ± 1.9 0.0001**
Recall with clues 7.8 ± 3.4 11.2 ± 0.92 0.0001**
Recognition 10.4 ± 1.9 11.7 ± 0.42 0.035*
BSRT 6.1 ± 2.1 7.47 ± 1.18 0.005*
BSRTfr 6.8 ± 1.5 7.6 ± 1.05 0.013*
Boston Naming test 44.2 ± 8.6 52.9 ± 4.0 0.001*
Semantic fluency 13.6 ± 5.1 20.1 ± 4.7 0.0001**
Phonological fluency 11.3 ± 5.5 15.4 ± 3.4 0.0001**
TMA 72.6 ± 48 50.8 ±18 0.001*
Digit Span forward 5.1 ± 1.2 6.1 ± 1.0 0.002*
Digit Span backward 3.7 ± 1.07 4.59 ± 1.3 0.004*
TMB 239 ± 165 115± 43 0.009*
Clock drawing test 5.26 ± 2.3 6.6 ± 0.6 0.045*
References: BSRT: Buschke Selective Reminding Test, free recall; Buschke
Selective Reminding Test, free recall (BSRT fr); TMA; Trail Making test A; TMB:
Trail making test B
Table 9: Neuropsychological tests. Depressive (baseline) vs normal
controls.




Patient, mean 0.5 (0-9) 1 (0-6) 1.68 (0-14)
Relative, mean 1.25 (0-7) 1.68 (0-9) 2.05 (0-8)
Table 10: Activities of daily living.
Follow-up results
Thirty nine patients (38.6%) were contacted but did not attend the
follow-up visits, and sixty one patients were evaluated (61.4%) and
followed-up. In this last group, only thirty six patients continue with
the antidepressant treatment indicated at the baseline visit.
Of the patients who were in antidepressant treatment (n=36) 46.6%
said they had a response from excellent to good to antidepressant
treatment, and 13.3% had a response from fair to poor. Of all patients
in follow-up (n=61) 41.6% received prior antidepressant treatment.
From these, 28% said to have responded well to previous
antidepressant treatment, and 72% had a fair to poor response. The
main causes of poor response were adverse effects, low-dose and
treatment neglect.
Of the reevaluated patients, 56.6% improved in any area either
cognitive or mood. Improvement was described in the mood (anxiety
and depression) and into cognitive functions (memory, attention,
executive functions and language) (Table 11). The greatest
improvement was observed in depression and anxiety affective spheres.
Within the cognitive profile, memory was the most improved function,
and, secondly, attention (Tables 12 and 13).
Variables Improved No changes Decreased
Anxiety/Depression 31 11 19
Memory 18 13 11
Attention 14 15 10
Executive functions 5 20 11
Language 4 21 6
Table 11: Follow-up. Patient’s response to antidepressant treatment.
Variable Baseline N=101 Follow up N=61 P
Hamilton Anxiety Scale 17.5 ± 8 10.2 ± 8.1 <0.001
Hamilton Depression
Scale
18.1 ± 6 11.6 ± 8.3 <0.001
Beck Depression
Inventory
22.7 ± 10 17.5 ± 12 0.009
Table 12: Neuropsychiatric test. Depressive patients at baseline
compared to follow up visit.
Discussion
With the results obtained in this research we arrived to the following
conclusions:
Demographic data
There was a significant predominance of female patients, 79.7% of
the studied population. Prospective studies reveal more incidence of
major depression among women compared to men [31,32], this could
be considered as a predisposing factor for the development of the
disease. From the observed population, 58.5% is married; the rest is
divorced, widowed, single or separate. Widowhood, singleness and
separation or divorce are risk factors for developing depression [33-
36]. With regard to educational level average in our patients is about
8.73 (SD 4.4) years, where most of the patients completed primary
school. Low education is a risk factor for depression [32].
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Diagnosis of depression mood disorder
In this study population, they were found in decreasing order 36.3%
of patients with major depression (according to DSM-IV and ICD-10),
and 34.3% of patients with dysthymia (according to DSM IV and
ICD-10. From the patients with Major Depressive Disorder, 7 of them
had bipolar disorder. Of the patients with Depression due to Medical
Conditions (n=26, 25.7%): 10 had Vascular Dementia, 10 Alzheimer’s
type Dementia and 6 Frontotemporal type Dementia. All of them were
scored CDR 1 (mild dementia).
In the geriatric population, it could be considered that neurological
diseases, such as vascular and degenerative dementia, become








MMSE 26.2 ± 3.2 26.1 ± 3.7 NS
Pfeiffer 1.22 ± 1.3 1.52 ± 1.2 NS
Paragraph recall 4.66 ± 2.43 5.2 ± 2.9 NS
Paragraph delay recall 4.27 ± 2.5 4.84 ± 2.9 NS
List of words 7 ± 2.44 7.1 ± 2.45 NS
Retention 4.9 ± 3.1 5.3 ± 3.1 NS
Recall with clues 7.8 ± 3.4 8.2 ± 3.3 NS
Recognition 10.4 ± 1.9 10.2 ± 2.5 NS
BSRT 6.1 ± 2.1 5.79 ± 2.7 NS
BSRTfr 6.8 ± 1.5 6.6 ± 1.7 NS
Boston Naming test 44.2 ± 8.6 43.9 ± 8.9 NS
Semantic fluency 13.6 ± 5.1 14.8 ± 6.8 NS
Phonological fluency 11.3 ± 5.5 11.1 ± 5.3 NS
TMA 72.6 ± 48 93.9 ± 76 NS
Digit Span forward 5.1 ± 1.2 5.1 ± 1.2 NS
Digit Span backward 3.7 ± 1.07 3.5 ± 0.9 NS
TMB 239 ± 165 293 ± 181 NS
Clock drawing test 5.26 ± 2.3 5.26 ± 2.3 NS
References: MMSE: Minimental State Examination; BSRT: Buschke Selective
Reminding Test, free recall; Buschke Selective Reminding Test, free recall
(BSRT fr); TMA; Trail Making test A; TMB: Trail making test B
Table 13: Neuropsychological Tests. Depressive patients at baseline
compared to follow-up.
Risk factors
In the present study we considered medical, psychiatric and
sociological risk factors.
There is an assumption of executive dysfunction in late-onset
depression [30,38,39]. This hypothesis suggests that a subgroup of
elderly people with depression, with fronto-striatal dysfunction caused
by cerebrovascular disease or other age-related conditions, would be
the main predisposing factor for depression [30].
In previous studies depression was associated with concomitant
diseases [34], previous personality, altered functional status [33],
alcohol abuse [40], hypothyroidism and lack of family support.
Of the evaluated risk factors (including both vascular and
depression themselves) no significant differences (p <0.05) were found
compared to normal controls in variables as HTA, DBT, smoking,
alcohol consumption, concomitant diseases, and marital status. On the
other hand, significant differences were found (p <0.05) in patients
with dyslipidemia (OR 3.3, CI 1.16-9.6), heart disease (OR 4.4, CI
1.01-20.6), cerebrovascular disease (OR 8.5, CI 1.1-66.7), currently
active or working (OR 6.5, CI 2.26-18.8), inadequate family support
(OR 3.2, CI 1.04-10.35), and family history of depression (OR 3.6, CI
1.01-12.9). Yaka et al. reported that the following variables were risk
factors for depression: obstructive pulmonary disease, psychiatric
disease, cerebrovascular disease, low income and being dependent
[41]. Moreover, a meta-analysis showed that, compared with the
elderly without chronic disease, those with chronic disease had higher
risk for depression [42]. The lack of activity or work produces a relative
risk of 6.5 of developing depression.
Cognitive functions
Depression is a mental illness that affects not only psychologically
(mood disorder) but also cognitively (through cognitive impairment)
[43,44]. Depression in older patients could be an expression of
neuronal degeneration and initial symptom of a dementia [44]. This
should be considered in any patient that begins his/her depression
after he/she is 60 years old (late-onset depression).
Daily life activities
It was observed that, in general, patients had some degree of
dependence (partial dependence) in activities of daily living. This
certainly increases the overload (the average overload found in our
sample was mild to moderate). It was noted that increase degrees of
depression increases the patient's dependence.
Depression causes a reduction in the active life of 4 years [45].
Depression causes an alteration in the functional status of people,
damaging both the quality of life of patients and their environment
(family overload) [46].
As the degree of depression increases, the dependence of the patient
and family overload also increase. All this leads to generate significant
health expenditures increasing costs associated with this disease [47].
Antidepressant treatment
47.7% of depressive patients included in this work were without
antidepressant treatment at baseline visit. This shows the lack of
information received by general population about this disease, and
hence the low demand for medical care.
Recurrence and relapse
54.4% of evaluated patients (41 patients) had recurrence and/or
recurrence of their depressive symptoms throughout their lives.
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Follow-up
We recruited 101 depressive patients and 25 normal controls at
baseline, then proceeded to see the evolution of these depressive
patients who spent at least 6 months after their first visit.
We contacted all patients but only 61 of them could be reevaluated,
(60.4%). Remaining patients were summoned for missing evaluations
(at least cited twice). Of contacted and reassessed patients only 60%
receive antidepressant treatment, despite the indication of treatment to
all patients enrolled in 2005-2006.
Of the patients who are in antidepressant treatment (n=36) 46.6%
said they had an excellent to good response to antidepressant, and
13.3% had a response from fair to poor. Of all patients in follow-up
(n=61) 41.6% received prior antidepressant treatment. They responded
excellent to good to previous antidepressant treatment in 28% of cases,
and fair to poor in 72%. The main cause of fair to poor response was
adverse effects, low-dose and treatment neglect.
Of the reevaluated patients 56.6% improved in any area, either
cognitive or mood. The greatest improvement was observed in
depression and anxiety affective spheres. Within the cognitive profile,
memory was the most improved function, and, secondly, attention.
Statistically analysis (Student test for related samples) of results
obtained in the different neuropsychiatric and neuropsychological
scales, informed significant differences (p<0.05) in neuropsychiatric
scales between the initial assessment and reassessment (Hamilton
anxiety scale, Hamilton depression and Beck depression).
As it had been reported in other studies, the present work shows
that there is a predominance of women in the depression patients
group [31,48] and a high percentage of depressed patients without any
social support [41,49].
An important prevalence and incidence of depression in the elderly
population was observed. Nevertheless, a high percentage of patients
do not receive or never received antidepressant treatment as it was
reported previously [50]. However, after receiving treatment, our
patients underwent an improvement in their affective state (anxiety,
depression).
Limitations
The following study is an epidemiological and case-control research
study with follow-up. It is not a randomized controlled trial. The data
obtained is descriptive and shows a trend that cannot be taken in
consideration as an specific response to a singular antidepressant
treatment. Moreover, the antidepressant treatment indicated had two
different medications [sertraline (25-50 mg/day) and escitalopram (10
mg/day)]. No reference to other medications is described in this
research, as it is out of the aims of the study. Also, patients at follow-up
were not divided in groups, all depressive patients were in a single
group; this can lead to certain bias in the results as patients with
dementia will not beneficiate as well as major depressive or dysthymia
patients. Therefore, when analyzing the results of the improvement of
the neuropsychological tests in the follow up visit, this should be taken
into consideration.
Conclusions
Depression is a prevalent disease in the elder population. It is
important to implement health policies to inform the community,
prevent associated risk factors, and promote appropriate treatments
and rehabilitation. This condition not only affects the patients but also
their environment.
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